Move opens market with growing rates of obesity to Danish group’s blockbuster drug
Novo Nordisk’s blockbuster weight-loss drug Wegovy has been approved for sale in China, opening the door to a huge market in which obesity rates have more than doubled among adults in the past two decades. The Danish pharmaceutical company said on Tuesday that Wegovy “has been approved in China for long-term weight management” for overweight and obese people.
5bn, even as it has struggled to meet huge demand for its products, at times prioritising the supply of the drugs to existing patients rather than new users. But semaglutide, the active ingredient in Wegovy and Ozempic, will lose exclusivity in China in 2026, potentially limiting the sales that the Danish drugmaker could generate in the country. Chinese drugmakers have begun to develop alternative weight-loss drugs that analysts expect could be on the market by 2026.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024Novo Nordisk today announced the presentation of 34 abstracts highlighting the breadth of its portfolio at the upcoming 84th Scientific Sessions of the American Diabetes Association (ADA).
Read more »
Superdrug selling Mounjaro and Wegovy in new weight loss serviceSuperdrug has announced it is expanding its face-to-face weight loss blood test service in stores across the UK
Read more »
Wegovy and Ozempic linked to reduced incidence and recurrence of alcohol abuse or dependence, study suggestsResearchers investigated the potential therapeutic benefits of semaglutide for alcohol use disorders.
Read more »
Weight loss jabs like Ozempic and Wegovy cut risk of bowel cancer by halfLeading doctor, Dr Mark Hyman, warns of deadly unforeseen side effects of Ozempic: 'It raises your risk 900 PERCENT' on The Diary of a CEO podcast.
Read more »
Weight loss jabs like Ozempic and Wegovy cut risk of bowel cancer by halfLeading doctor, Dr Mark Hyman, warns of deadly unforeseen side effects of Ozempic: 'It raises your risk 900 PERCENT' on The Diary of a CEO podcast.
Read more »
What are alternatives to Ozempic and Wegovy and are they safe?With summer around the corner, telehealth outlets and medical spas are going into hyperdrive advertising the sale of semaglutide, the active ingredient in popular weight-loss drugs Ozempic and Wegovy.
Read more »